medigraphic.com
SPANISH

Revista Mexicana de Cardiología

ISSN 0188-2198 (Print)
En 2019, la Revista Mexicana de Cardiología cambió a Cardiovascular and Metabolic Science

Ver Cardiovascular and Metabolic Science


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 2

<< Back Next >>

Rev Mex Cardiol 2005; 16 (2)

The Second National Week of Hypertension of the Mexican Association for Preventing Atherosclerosis and its Complications (AMPAC). Results in Jalisco, México

González-Pliego JA, Olvera-Ruiz R, Velasco-Sánchez G, Cardona-Muñoz E, Hernández García H, Troyo-Sanromán R, Petersen-Farah A, Meaney-Mendiolea E, Álvarez-López H, Bolaños-Preciado M, Briseño-Ramírez H, Calvo Vargas C, De la Torre-Jiménez N, Duarte-Vega M, Esparragoza-Romano J, Farías-González V, Fernández-Valadez E, González-Marines D, Illescas-Díaz J, Lugo-Peña P, Montaño-Dorado J, Munguía del Toro D, Murguía-Suárez J, Najar-López S, Ontiveros-Godínez T, Orendain-González V, Ortiz-Galván F, Rentería-Ibarra R
Full text How to cite this article

Language: Spanish
References: 20
Page: 70-79
PDF size: 109.72 Kb.


Key words:

Hypertension, cross-sectional study, population survey, Jalisco, México; public health, epidemiology.

ABSTRACT

Objective: The Second National Week of Hypertension was performed to determine the current status of the prevalence of hypertension (HTA) and its relationship with traditional atherosclerosis risk factors. This paper shows the results from the population screened in Jalisco, Mexico. Methods: From October 21 to 26, 2002, a survey was carried out in Jalisco, Mexico where 18,277 individuals were screened. Data about the average of two blood pressure readings, weight, height, smoking, hypercholesterolemia, diabetes and personal and familiar history of myocardial infarction and cerebrovascular disease were included. Diagnosis of HTA was accepted in individuals with previous medical diagnosis, or high blood pressure (systolic › 140 mmHg and/or diastolic › 90 mmHg) detected during the interview; thereafter, the cases were classified as systolic, diastolic or combined HTA and its association with risk factors was evaluated. Results: 18,092 (98.9%) individuals were correctly screened for blood pressure and analyzed with the Statistical Program for the Social Sciences 10.0 software. The mean age was 44.8 yr. (SD ± 16.1 yr; min-10 yr, max 98 yr). The prevalence of HTA in Jalisco was 34.9% (38.5% in men and 33.2% in women) with 10.4% diagnosed in the screening (new cases). The prevalence was directly related with age and after 50 y.o., is › 50%; after 70 y.o., two of each three individuals had high blood pressure. The percentage of persons with HTA who were unaware that they have high blood pressure was 29.86%; among persons with HTA diagnosed in the screening 15.4% were men and 7.8% were women; women were more participative than men. In 65.6% of people with HTA previously known, antihypertensive drug therapy was detected and the total percentage of HTA controlled with drugs was 19.6% (n = 1,242). The odds ratio (OR) for HTA were: for personal history of HTA 6.87 (C.I.95% 6.37-7.42); for hypercholesterolemia 2.42 (C.I.95% 2.19-2.67); for diabetes 2.41 (C.I.95% 2.19-2.65); for obesity 2.03 (C.I.95% 1.88-2.20); for smoking 1.03 (C.I.95% 0.94-1.1, NS). Conclusions: The prevalence of HTA in Jalisco is among the highest in Mexico and the number of new diagnosed cases increases notably. The personal history of HTA, diabetes, hypercholesterolemia and obesity but not of smoking, increases the risk for developing HTA.


REFERENCES

  1. Estadísticas de mortalidad en México: muertes registradas en el año 2002. Salud Pública Mex 2004; 46: 169-185.

  2. Chávez DR, Ramírez HJ, Casanova GJ. La cardiopatía coronaria en México y su importancia clínica, epidemiológica y preventiva. Arch Cardiol Mex 2003; 73: 105-114.

  3. Velázquez-Monroy O, Rosas PM, Lara EA, Pastelín HG, Grupo ENSA 2000, Sánchez CC et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003; 73: 62-77.

  4. Velázquez MO, Rosas PM, Lara EA, Pastelín HG, Grupo ENSA 2000, Attie F et al. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002; 72: 71-84.

  5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 141: 2746-2753.

  6. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855-2864.

  7. Ounpuu S, Negassa A, Yusuf S. INTER-HEART: a global study of risk factors for acute myocardial infarction. Am Heart J 2001; 141: 711-721.

  8. Arroyo P, Fernández V, Loria A, Kuri-Morales P, Orozco-Rivadeneyra S, Olaiz G et al. Hypertension in urban Mexico: the 1992-93 national survey of chronic diseases. J Hum Hypertens 1999; 13: 671-675.

  9. Posadas RC, Yamamoto KL, Tapia-Conyer R. Epidemiología de las dislipidemias en México. En: Dislipidemias y Aterosclerosis. 2ª Edición. Editado por Posadas RC. Interamericana. M McGraw-Hill: México, D.F., 1996: 117-130.

  10. Encuesta Nacional de Salud. Jalisco. Guadalajara: Secretaría General de Gobierno del Estado de Jalisco, Unidad Editorial; 1988.

  11. González-Pliego JA, León ZR. Conceptos actuales sobre la enfermedad hipertensiva sistémica en la senectud. Arch Cardiol Mex 1990; 60: 99-108.

  12. Flegal KM, Troyano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995; 333: 1165-1170.

  13. Halimi JM, Girardeau B, Vol S, Caces H, Nivet H, Ticket J. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 2002; 20: 187-193.

  14. McKusick VA. Genetics and the nature of essential hypertension. Circulation 1960; 22: 857.

  15. Kaplan N. Systemic hypertension. Mechanisms and diagnosis. In: Braunwald E et al (eds). Heart Disease. 6th Ed. Philadelphia, WB Saunders, 2001.

  16. Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 2003; 88: 2399-2403.

  17. Grupo de Estudio del Síndrome Metabólico. Consenso Mexicano sobre el Tratamiento integral del Síndrome Metabólico. Rev Mex Cardiol 2002; 13: 4-30.

  18. Dirección General de Epidemiología Instituto Nacional de Nutrición “Salvador Zubirán”. Encuesta Nacional de Enfermedades Crónicas 1993.

  19. Aguilar SC, Rojas R, Gómez-Pérez F, Valles V, Franco A, Olaiz G et al. Características de los casos con dislipidemias mixtas en un estudio de población: resultados de la Encuesta Nacional de Enfermedades Crónicas. Salud Pública Mex 2002; 44: 546-553.

  20. Lara A, Rosas M, Pastelín G, Aguilar C, Attie F, Velásquez-Monroy O. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004; 74: 231-245.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cardiol. 2005;16